193 related articles for article (PubMed ID: 37469482)
1. A rat model of metabolic syndrome-related heart failure with preserved ejection fraction phenotype: pathological alterations and possible molecular mechanisms.
Shi Y; Liu C; Yang C; Qiao W; Liu Y; Liu S; Dong G
Front Cardiovasc Med; 2023; 10():1208370. PubMed ID: 37469482
[TBL] [Abstract][Full Text] [Related]
2. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction.
Shi YJ; Yang CG; Qiao WB; Liu YC; Liu SY; Dong GJ
Eur J Pharmacol; 2023 Dec; 961():176170. PubMed ID: 37939991
[TBL] [Abstract][Full Text] [Related]
3. Ling-Gui-Qi-Hua formula alleviates left ventricular myocardial fibrosis in rats with heart failure with preserved ejection fraction by blocking the transforming growth factor-β1 /Smads signaling pathway.
Shi Y; Liu C; Xiong S; Yang L; Yang C; Qiao W; Liu Y; Liu S; Liu J; Dong G
J Ethnopharmacol; 2023 Dec; 317():116849. PubMed ID: 37385575
[TBL] [Abstract][Full Text] [Related]
4. Effects and mechanism of Compound Qidan Formula on rats with HFpEF induced by hypertension and diabetes mellitus based on Ang Ⅱ/TGF-β1/Smads signaling pathway.
Yuan P; Liu J; Xiong S; Yang L; Guan J; Dong G; Shi D
J Ethnopharmacol; 2023 Sep; 313():116558. PubMed ID: 37116729
[TBL] [Abstract][Full Text] [Related]
5. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
Paulus WJ; Tschöpe C
J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
7. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype.
Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR
Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506
[TBL] [Abstract][Full Text] [Related]
8. Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models.
van Ham WB; Kessler EL; Oerlemans MIFJ; Handoko ML; Sluijter JPG; van Veen TAB; den Ruijter HM; de Jager SCA
JACC Basic Transl Sci; 2022 Aug; 7(8):844-857. PubMed ID: 36061340
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction.
Zhang L; Chen J; Yan L; He Q; Xie H; Chen M
Front Pharmacol; 2021; 12():646240. PubMed ID: 34177571
[No Abstract] [Full Text] [Related]
10. A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities.
Hubesch G; Hanthazi A; Acheampong A; Chomette L; Lasolle H; Hupkens E; Jespers P; Vegh G; Wembonyama CWM; Verhoeven C; Dewachter C; Vachiery JL; Entee KM; Dewachter L
Front Cardiovasc Med; 2021; 8():809885. PubMed ID: 35097026
[TBL] [Abstract][Full Text] [Related]
11. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
[TBL] [Abstract][Full Text] [Related]
12. Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction.
de Couto G; Mesquita T; Wu X; Rajewski A; Huang F; Akhmerov A; Na N; Wu D; Wang Y; Li L; Tran M; Kilfoil P; Cingolani E; Marbán E
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H892-H903. PubMed ID: 36083797
[TBL] [Abstract][Full Text] [Related]
13. Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF.
Hohendanner F; Bode D; Primessnig U; Guthof T; Doerr R; Jeuthe S; Reimers S; Zhang K; Bach D; Wakula P; Pieske BM; Heinzel FR
J Mol Cell Cardiol; 2018 Feb; 115():10-19. PubMed ID: 29289652
[TBL] [Abstract][Full Text] [Related]
14. Pressure Overload Activates DNA-Damage Response in Cardiac Stromal Cells: A Novel Mechanism Behind Heart Failure With Preserved Ejection Fraction?
Stadiotti I; Santoro R; Scopece A; Pirola S; Guarino A; Polvani G; Maione AS; Ascione F; Li Q; Delia D; Foiani M; Pompilio G; Sommariva E
Front Cardiovasc Med; 2022; 9():878268. PubMed ID: 35811699
[TBL] [Abstract][Full Text] [Related]
15. Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation.
Gallet R; de Couto G; Simsolo E; Valle J; Sun B; Liu W; Tseliou E; Zile MR; Marbán E
JACC Basic Transl Sci; 2016; 1(1-2):14-28. PubMed ID: 27104217
[TBL] [Abstract][Full Text] [Related]
16. Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
Franssen C; Chen S; Unger A; Korkmaz HI; De Keulenaer GW; Tschöpe C; Leite-Moreira AF; Musters R; Niessen HW; Linke WA; Paulus WJ; Hamdani N
JACC Heart Fail; 2016 Apr; 4(4):312-24. PubMed ID: 26682792
[TBL] [Abstract][Full Text] [Related]
17. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte Functional Etiology in Heart Failure With Preserved Ejection Fraction Is Distinctive-A New Preclinical Model.
Curl CL; Danes VR; Bell JR; Raaijmakers AJA; Ip WTK; Chandramouli C; Harding TW; Porrello ER; Erickson JR; Charchar FJ; Kompa AR; Edgley AJ; Crossman DJ; Soeller C; Mellor KM; Kalman JM; Harrap SB; Delbridge LMD
J Am Heart Assoc; 2018 Jun; 7(11):. PubMed ID: 29858360
[TBL] [Abstract][Full Text] [Related]
19. SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction.
Lai YC; Tabima DM; Dube JJ; Hughan KS; Vanderpool RR; Goncharov DA; St Croix CM; Garcia-Ocaña A; Goncharova EA; Tofovic SP; Mora AL; Gladwin MT
Circulation; 2016 Feb; 133(8):717-31. PubMed ID: 26813102
[TBL] [Abstract][Full Text] [Related]
20. A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction.
Schwarzl M; Hamdani N; Seiler S; Alogna A; Manninger M; Reilly S; Zirngast B; Kirsch A; Steendijk P; Verderber J; Zweiker D; Eller P; Höfler G; Schauer S; Eller K; Maechler H; Pieske BM; Linke WA; Casadei B; Post H
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1407-18. PubMed ID: 26342070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]